Abstract
A series of consecutive unselected patients with primary breast carcinoma and their age-matched controls were studied for serum CEA in relation to clinical findings. Raised CEA was found in a similar frequency in patients with primary breast cancer (pre- and postoperative) and in the control women: 16%, 11% and 11%, respectively, exceeded the selected upper limit of the reference range (13 ng/ml) with a double-antibody radioimmunoassay. In the breast-cancer patients, however, 48% of the raised CEA levels exceeded 16 ng/ml, compared with only 20% in the controls. Significant correlations (r approximately 0.3) were found between CEA levels and tumour size, TNM classification and a combined clinical and histopathological classification. A high frequency of raised CEA values in the advanced breast-cancer patients was the essential contribution to these positive correlations. A correlation coefficient of 0.6 was found between pre- and postoperative CEA values. The frequency of smoking and/or chronic disease was unexpectedly high in patients as well as in controls with high CEA.
MeSH Terms
Adult
Age Factors
Aged
Breast Neoplasms/immunology,pathology,surgery
Carcinoembryonic Antigen/analysis
Chronic Disease
Female
Humans
Middle Aged
Postoperative Period
Radioimmunoassay
Smoking/complications
Chemicals
Carcinoembryonic Antigen
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Rimsten A
Adami H O
Wahren B
Nordin B
References (16)
16 references, click to expand
-
Significance of CEA determinations in patients with cancer of the colon-rectum and the mammary gland in comparison to physiological states in connection with pregnancy.
Bull Cancer. 1976 Oct-Dec;63(4):575-86
PMID: 1021185
-
Carcinoembryonic antigen and other tumor markers in tissue and serum or plasma of patients with primary mammary carcinoma.
Cancer. 1978 Oct;42(4):1870-8
PMID: 361213
-
A method for estimating bias introduced into epidemiological investigations by those who refuse to participate.
Ann Clin Res. 1978 Feb;10(1):38-42
PMID: 677800
-
Biological markers in breast carcinoma. III. Clinical correlations with carcinoembryonic antigen.
Cancer. 1977 Jun;39(6):2397-404
PMID: 872038
-
Carcinoembryonic antigen (CEA) in patients with breast cancer.
Eur J Cancer. 1977 Feb;13(2):171-6
PMID: 852488
-
Radioimmunoassay of carcinoembryonic antigen and clinical significance of its level in plasma.
Gan. 1976 Jun;67(3):371-8
PMID: 1001864
-
Carcinoembryonic antigen (CEA) assay. A laboratory adjunct in the diagnosis and management of cancer.
Hum Pathol. 1974 Mar;5(2):139-47
PMID: 4811605
-
Immunology and colonic cancer: further evaluation of the radioimmunoassay for carcinoembryonic antigen of the human digestive system as an adjunct in cancer diagnosis.
Dis Colon Rectum. 1973 Sep-Oct;16(5):358-65
PMID: 4775052
-
Carcinoembryonic antigen in breast cancer patients: serum levels and disease progress.
Cancer. 1974 May;33(5):1246-52
PMID: 4823478
-
Evaluation of carcinoembryonic antigen in human mammary carcinoma.
J Natl Cancer Inst. 1973 Oct;51(4):1119-22
PMID: 4745852
-
Role of plasma carcinoembryonic antigen in diagnosis of gastrointestinal, mammary, and bronchial carcinoma.
Br Med J. 1972 Sep 9;3(5827):605-9
PMID: 5071695
-
Relationship between plasma carcinoembryonic antigen and prognosis in women with breast cancer.
Eur J Cancer. 1975 Sep;11(9):615-8
PMID: 1220977
-
Carcinoembryonic antigen: clinical and historical aspects.
Cancer. 1976 Jan;37(1):62-81
PMID: 1247968
-
Measurement of urinary CEA-like substance. An aid in management of patients with bladder carcinoma.
Cancer. 1975 Oct;36(4):1490-5
PMID: 1175143
-
Prognostic factors in colon carcinoma: correlation of serum carcinoembryonic antigen level and tumor histopathology.
Hum Pathol. 1975 Jan;6(1):31-45
PMID: 1110084
-
Biological markers in breast carcinoma. I. Incidence of abnormalities of CEA, HCG, three polyamines, and three minor nucleosides.
Cancer. 1975 Apr;35(4):1095-100
PMID: 1116102